oxonic acid has been researched along with Pyloric Stenosis in 9 studies
Oxonic Acid: Antagonist of urate oxidase.
Pyloric Stenosis: Narrowing of the pyloric canal with varied etiology. A common form is due to muscle hypertrophy (PYLORIC STENOSIS, HYPERTROPHIC) seen in infants.
Excerpt | Relevance | Reference |
---|---|---|
"A 72-year-old man with advanced gastric cancer was referred to our hospital." | 2.49 | [A case of locally advanced gastric cancer in which pathological complete response( PCR) was obtained after combination chemotherapy with S-1/cisplatin]. ( Fujino, M; Hasegawa, A; Kametaka, H; Koyama, T; Makino, H; Matsuo, M; Seike, K; Yokoyama, M, 2013) |
"We report a case of advanced gastric cancer with pyloric stenosis, in which a curative resection was performed following gastrojejunostomy and S-1 based chemotherapy." | 1.38 | [Distal gastrectomy for initially unresectable gastric cancer with pyloric stenosis following gastrojejunostomy and S-1 plus CDDP chemotherapy]. ( Kawai, T; Kinoshita, K; Kobayashi, S; Kusano, M; Miyagishima, T; Nagasako, Y; Ogasawara, K; Sunahara, M; Takahashi, M, 2012) |
"We report a patient with an advanced gastric cancer complicated by pyloric stenosis who was effectively treated by S-1 mono-therapy after gastrojejunostomy." | 1.35 | [Gastrojejunostomy for irresectable gastric cancer with pyloric stenosis-new role of surgery in the era of S-1]. ( Fujiwara, Y; Hayashi, C; Kobayashi, M; Koishi, K; Kojima, S; Matsumoto, T; Miwa, H; Sasako, M; Tanaka, J; Tomita, N; Yamamoto, N; Yamamura, T, 2009) |
"We report a patient with unresectable gastric cancer who was effectively treated with S-1 after gastrojejunostomy." | 1.34 | [A case of unresectable gastric cancer complicated by serious pyloric stenosis in which S-1 administration after gastrojejunostomy proved effective]. ( Fujii, M; Hirota, M; Matsuda, C; Mikata, S; Morimoto, Y; Nishikawa, K; Tanaka, Y, 2007) |
"At laparotomy to improve anemia and pyloric stenosis in September 2001, lymphnode metastases invaded the stomach and the pancreatic body." | 1.33 | [A case of advanced gastric cancer treated by TS-1 for 3 years and 7 months]. ( Ishizuka, D; Kobayashi, K; Tada, T; Ueki, K; Wakakuwa, R, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (55.56) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujino, M | 2 |
Kametaka, H | 1 |
Makino, H | 1 |
Yokoyama, M | 1 |
Matsuo, M | 1 |
Seike, K | 1 |
Koyama, T | 1 |
Hasegawa, A | 1 |
Michiura, T | 1 |
Miyazaki, S | 1 |
Fujita, S | 1 |
Hirose, H | 1 |
Miyazaki, Y | 1 |
Sugimoto, S | 1 |
Yamabe, K | 1 |
Nagaoka, M | 1 |
Nishikawa, K | 2 |
Iwase, K | 1 |
Fujii, M | 2 |
Matsuda, C | 2 |
Shimada, K | 1 |
Hirota, M | 2 |
Kimura, T | 1 |
Wada, D | 1 |
Nasu, S | 1 |
Tanaka, Y | 2 |
Matsumoto, T | 1 |
Fujiwara, Y | 1 |
Yamamoto, N | 1 |
Hayashi, C | 1 |
Koishi, K | 1 |
Kojima, S | 1 |
Tanaka, J | 1 |
Kobayashi, M | 1 |
Yamamura, T | 1 |
Miwa, H | 1 |
Tomita, N | 1 |
Sasako, M | 1 |
Matsushima, Y | 1 |
Kawabata, R | 1 |
Imamura, H | 1 |
Kishimoto, T | 1 |
Hachino, Y | 1 |
Yasui, Y | 1 |
Fujii, C | 1 |
Fukunaga, M | 1 |
Ohzato, H | 1 |
Furukawa, H | 1 |
Sunahara, M | 1 |
Kawai, T | 1 |
Nagasako, Y | 1 |
Kobayashi, S | 1 |
Takahashi, M | 1 |
Ogasawara, K | 1 |
Kusano, M | 1 |
Kinoshita, K | 1 |
Miyagishima, T | 1 |
Kobayashi, K | 1 |
Ueki, K | 1 |
Wakakuwa, R | 1 |
Ishizuka, D | 1 |
Tada, T | 1 |
Morimoto, Y | 1 |
Mikata, S | 1 |
Ishii, N | 1 |
Fujitani, S | 1 |
Suzuki, S | 1 |
Tsukamoto, M | 1 |
Arai, M | 1 |
Hashimoto, A | 1 |
Izuka, Y | 1 |
Fukuda, K | 1 |
Horiki, N | 1 |
Fujita, Y | 1 |
1 review available for oxonic acid and Pyloric Stenosis
Article | Year |
---|---|
[A case of locally advanced gastric cancer in which pathological complete response( PCR) was obtained after combination chemotherapy with S-1/cisplatin].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastric Bypass; | 2013 |
8 other studies available for oxonic acid and Pyloric Stenosis
Article | Year |
---|---|
[A case of advanced HER2- positive gastric cancer with a partial response to molecular targeted chemotherapy (S-1+CDDP+Trastuzumab)].
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug C | 2014 |
[Administration of S-1 after gastrojejunostomy for unresectable gastric cancer with pyloric stenosis].
Topics: Aged; Aged, 80 and over; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Case-Contr | 2009 |
[Gastrojejunostomy for irresectable gastric cancer with pyloric stenosis-new role of surgery in the era of S-1].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Drug Combinations; Fatal Outcome; | 2009 |
[Gastrojejunostomy followed by chemotherapy with S-1 in unresectable gastric cancer with pyloric stenosis].
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Com | 2012 |
[Distal gastrectomy for initially unresectable gastric cancer with pyloric stenosis following gastrojejunostomy and S-1 plus CDDP chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Combinati | 2012 |
[A case of advanced gastric cancer treated by TS-1 for 3 years and 7 months].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Comb | 2006 |
[A case of unresectable gastric cancer complicated by serious pyloric stenosis in which S-1 administration after gastrojejunostomy proved effective].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Camptothecin; Combined Modality | 2007 |
[A case of advanced gastric cancer with pyloric stenosis and obstructive jaundice responding to s-1/paclitaxel combination therapy after endoscopic balloon dilatation and endoscopic biliary drainage].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Diseases; Catheterization; Drug | 2008 |